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Compelling evidences indicate that dietary factors can contribute to human cancer risk and as such 
many of the cancers common in the third world countries and the western world, including liver, colon, 
prostate and breast cancers have been related to dietary behaviors. Dietary carcinogens identified to 
date include the mycotoxins, heterocyclic amines formed from heat treatment of meat, N-nitroso 
compounds and the polycyclic aromatic hydrocarbons. It has been recognized that diet-related cancers 
occur through an imbalance of carcinogenesis and anticarcinogenesis. Dietary anticarcinogens may 
therefore provide a means of retarding, suppressing or reversing the multi-stage carcinogenesis. An 
avalanche of dietary and plant-derived compounds has been reported to possess anticarcinogenic 
activities. Most of these agents possess intrinsic antioxidant, radical trapping and anti-inflammatory 
properties, which appear to contribute to their chemo preventive properties. Resveratrol, a phytoalexin, 
present in grapes, berries and peanuts and Curcumin the natural yellow pigment in turmeric isolated 
from the rhizome of the plant Curcuma longa elicit striking inhibitory effects on diverse cellular events 
associated with the process of carcinogenesis. Lycopene, a carotenoid present in tomatoes is a 
powerful quencher of singlet oxygen. Epidemiological evidence strongly suggests that lycopene 
consumption and tomato products contribute to prostate cancer risk reduction. Kolaviron, a natural 
biflavonoid antioxidant obtained from the seeds of Garcinia kola has been extensively investigated for it 
hepatoprotective, radical scavenging and antigenotoxic properties in vitro and in vivo. Each of these 
anticarcinogens alone or in combination could  provide a sustainable chemopreventive intervention 
that might be useful in retarding the progress of cancer in different populations of the world. 
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Among various diseases attributed to mortality in humans 
all over the world, cancer is a leading cause. Dietary 
factors continue to play a complex and multifaceted role 
in the aetiology of cancer. Apart from cigarette smoking 
and chronic inflammation and infection, nutrition accounts 
for up to one third of the total cause of cancer (Sugimura, 
2002). Cancers most commonly associated with diet 
include esophageal, stomach, colon, liver and the 
prostate. 
It is well known that most communities feed on 
substances of plant and animal origin which most of the 
times contain before processing chemicals, which are 
toxic. Of particular interest to toxicologists and 
nutritionists world wide particularly in the underdeveloped 
nations are the mycotoxins such as aflatoxins, which are 
metabolites of certain strains of fungi. These fungi occur 
principally in soil and decayed vegetation but can 
contaminate food accidentally. In addition, another group 
of toxins are the fumonisins which are the most important 
field fungi of maize in Africa and other parts of the world. 
Fusarium species have been shown to produce over 100 
secondary metabolites that can  adversely  affect  human  




and animal health (Visconti, 2001). Other specific diet-
related compounds of concern are the polycyclic aromatic 
hydrocarbons from roasted and charcoaled grilled meats, 
N-nitroso compounds that are found in cooked or cured 
meat and emanating from nitrites. Pyrrolizidine alkaloids 
in plants, which are used as medicinal herbs, also 
present a serious risk. These substances have been 
identified and shown to act as carcinogens in initiating 
early stages of cancer (Ferguson, 1999). 
In light of the considerable complexity of dietary 
substances, it is not surprising that in addition to 
mutagenic and carcinogenic components present in the 
diet, there may exist anticarcinogenic and antimutagenic 
substances. Thus certain plant-derived and dietary 
agents have been identified to play a role in the 
chemoprotection and chemoprevention of diseases 
caused by dietary carcinogens. This paper examines the 
present state of knowledge on certain diet-related toxic 
substances known to cause cancer at some specific sites 
in the human body and the possibility of preventing these 
cancers using dietary anticarcinogens. 
 
 




 Aflatoxin B1, the commonest of the aflatoxins is 
produced by Aspergillus flavus (Bradburn et al., 1993). 
Studies have related exposure of humans to aflatoxin B1 
to cancer risk. Although, aflatoxin B1 synergies hepatitis 
B and C infections in the causation of liver cancer 
(Turner, 2000), both laboratory and epidemiological data 
have established the role of aflatoxin in liver 
carcinogenesis (Groopman et al. 1999). It has been 
shown that aflatoxin B1 exposure occurs through the 
consumption of mold-contaminated groundnuts, grains 
and animal feed (Wogan, 1992), which can be 
transmitted transplacentally (Denning et al., 1990) and to 
new borns via breast-feeding (Wild et al., 1987). Aflatoxin 
contamination has also been linked to male infertility. 
Recently in a study conducted by Uriah et al. (2001) in 
Nigerian men, the blood and semen aflatoxin levels 
ranged from 700 to 1393 ng/ml and 60 to148 ng/ml in 
infertile and fertile men, respectively. Aflatoxin B1 is 
known to induce cancer via metabolic activation by 
CYP3A4, CYP3A5 and/ or CYP1A2  (Ueng et al., 1995; 
Wang et al., 1998) to exo-8,9-epoxide which can form 
adduct with DNA leading to guanine nucleotide 
substitutions (Lilleberg et al., 1992) specifically to codon 
249 of the p53 gene (Aguilar et al., 1993). 
Epidemiological studies have shown increased codon-
249 p53 mutations in areas of high aflatoxin B1 exposure 
(Greenblatt et al., 1994). Since hepatitis B virus and 
aflatoxin exposure have also been linked to 
hepatocellular carcinoma, recent studies have shown the 
interactive effect of increasing p53  mutation  in  persons 









Fumonisin was discovered in South Africa in 1988 
(Marasas, 1995). Fumonisins are a family of toxic and 
carcinogenic mycotoxins produced by Fusarium 
verticillioides (formerly Fusarium moniliforme), a common 
fungal contaminant of maize (Marasas et al., 2004). 
Fumonisins have received considerable attention by 
researchers and have been implicated in the aetiology of 
a number of diseases such as rat liver cancer and 
haemorrhage in the brain of rabbits (Marasas, 1995). 
Fumonisin was reported to induce apoptosis in cultured 
human cells (Tollenson et al., 1996) and nephrotoxicity in 
certain animals (Howard et al., 2001). 
Although experimental data have not conclusively 
linked fumonisin contaminated food to human health 
harzards, but some studies have associated consumption 
of maize contaminated with fuminisins to human 
oesophageal carcinoma in some parts of South Africa 
and China (IPCS, 2000). Recent studies have implicated 
reactive oxygen species (ROS) in fumonisin toxicity.  
Stockmann-Juvala et al. (2004) reported increase in lipid 
peroxidation, production of ROS, increase in caspase-3-
like protease activity, internucleosomal DNA 
fragmentation and intracellular reduction of glutathione in 






Ochratoxin A (OTA) is a mycotoxin produced as 
secondary metabolite by species of Aspergillus and 
Penicillium (Van der Merwe et al., 1965). It is found as 
contaminant in human foods, including various cereals, 
coffee, cocoa, wines and dried fruits. It is frequently 
associated with crops grown in semiarid and temperate 
regions and may not be a major problem in the tropics 
(Bankole and Adebanjo, 2003). Depending on the dose, 
OTA may be carcinogenic, genotoxic, immunotoxic or 
teratogenic (Neal and Judah, 2000). IARC has classified 
it in group 2B as possibly carcinogenic to humans (IARC, 
1993). The kidney has been shown to be a target organ 
in laboratory rodents and pigs (Kuiper-Godman and 
Scott, 1989). Exposure to OTA has been associated with 
the incidence of a kidney disease in humans, involving 
chronic interstitial nephritis as well as tumours of the 
urinary tract termed Baslkan Endemic Nephropathy 
(BEN) because of its geographical distribution (Petkova-
Bocharova et al., 1991). It has been reported that co-
occurrence of OTA with aflatoxin B1 in the same crop 
potentiates the mutagenic ability of the latter (Sedmkova 
et al., 2001).  
Studies have shown that the toxicity of OTA does not 
require metabolic activation in exposed individuals and 





however, involving specific target nature of some of the 
OTA-related toxicities and carcinogenesis suggests the 
involvement of metabolism in these processes (Neal and 
Judah, 2000). For instance studies using phenobarbitone 
or 3-methylcholanthrene pretreatment induced 4-hydroxy 
OTA, a metabolite of OTA by liver microsomes, 
suggesting the involvement of CYPs1A1/1A2, II B1 and 
IIA/111 A2 (Omar et al., 1996). On the other hand 
decreased CYP 450 levels were reported to increase the 
nepthrotoxicty of OTA, indicating a direct action of the 
parent compound in the metabolism. 
 
 
Polycyclic aromatic hydrocarbons 
 
Polycyclic aromatic hydrocarbons (PAH) are compounds 
formed during incomplete combustion of organic matter 
(Goldman and Shields, 2003). Many PAH have been 
established experimentally as carcinogens. Cigarette 
smoking has also been shown to contribute to PAH 
burden in man. However, it has been estimated that 
human diets provide 3 µg PAH/d, which compares to an 
exposure of 2-5 µg PAH/d per pack of cigarettes in a 
regular smoker (Goldman and Shields, 2003). Further 
studies to underscore PAH exposure from diet are the 
findings that intake of charcoal-broiled meat is more 
correlated to blood PAH-DNA adducts than smoking 
(Rothman et al., 1990).  
The major carcinogenic compounds among these are 
benzo(a)pyrene, 1,2,5,6-dibenzanthracene, 3-
methylcholanthrene, 7,12-dimethylbenz (a)anthracene 
and benz (a) anthracene (IARC, 1983). The target organs 
for PAH are the lung, breast, oropharynx, genitourinary 
and gastrointestinal tracts (Goldman and Shields, 2003). 
Our laboratory had screened for the presence of PAH in 
local foodstuffs available in the Nigeria market. 
Appreciable amounts of benz(a)anthracene and 
benzo(a)pyrene were found present in silver cat fish, 
African mid fish, moon fish, tilapia and smoked meat 
(suya) purchased from a popular market in Ibadan, 
Nigeria (Emerole et al., 1982). 
Benzo(a)pyrene represents the best characterized PAH 
compound obtained from the diet. In several animal 
species, administration of benzo(a)pyrene by different 
routes has been shown to result in the production of 
tumors. Thus the administration of a single oral dose of 
100 mg benzo(a)pyrene to 50-day- old rats produced 
mammary tumors in 8 out of 9 animals (Huggins and 
Yang, 1962). CYP 1A and CYP 1B are group of enzymes 
known to bring about metabolic activation of PAH to form 
epoxides. The bay-region diol epoxide binds to DNA as 
N2-deoxyguanosine adduct (Cheng et al., 1989). 
Benzo(a)pyrene adducts have been linked to cancer risk 
in the lung and they are also associated with site-specific 
hot spot mutations in the p53 tumor-suppressor gene 
(Greenblatt et al., 1994). 
In rodents, diets with PAH have been reported to 
consistently induce cancer of the foregut and lung tumors  




(Singh et al., 1998). Evidence abounds in humans that 
dietary exposure to PAH may induce colon cancer 
(Giovasnnucci et al., 1994). Both animal and human 
studies indicate that dietary PAH is distributed to other 
organs besides the locally exposed tissues thus dietary 





Organic N- nitroso compounds such as nitrosamines, 
occur either naturally in foods or as the product of in vivo 
reactions between ingested nitrite or nitrogen dioxides 
and secondary amines (Bababunmi et al., 1978). 
Nitrosamines have been shown to present serious health 
harzard. More than 80% of the nitrosamines tested in 
laboratory animals have been shown to be carcinogenic 
(Bartsch et al., 1987). Cancer of the liver, lung, kidney, 
mammary gland, stomach, pancreas, bladder or 
esophagus has been reported (Lijnsky, 1990). In 
humans, dietary nitrosamines have been implicated in the 
etiology of gastric, esophageal, nasopharyngeal and 
other gastrointestinal cancer (Bartsch et al., 1987). 
N-nitrosamines are considered an important carcinogen 
in parts of China and Japan (Goldman and Shields, 
2003). Nitrosamines have been detected in foods and 
local beverages in certain parts of Nigeria. A survey to 
determine the extent of the nitrosamine contamination of 
some popular fermented Nigerian beverages by dimethyl- 
and diethylnitrosamine was carried out in the Lagos, 
Ogun, Oyo, Ondo, Kwara and Benue States of Nigeria, 
following the mass spectrometric detection of these 
carcinogens in palm wine and nono (sour milk). The 
results indicated the contamination of drinks, namely, 
palm-wine, nono, pito, burukutu, and ogogoro, by both 
nitrosamines at the part per billion level (0.6 - 22 µg 
nitrosamine/l) (Maduagwu et al., 1979). N-nitroso 
compounds were also detected in commercially available 
samples of Nigerian lager beers and bottled palm wine, 
and of root cuttings of medicinal plants (Maduagwu and 
Uhegbu, 1986). Nitrosamines have also been shown to 
be formed by bacteria action. Evidence abounds to show 
that microorganisms in palm wine are involved in the 
formation of nitrosamine and that the rate of nitrosamine 
formation increases linearly with fermentation time 
(Joaquim, 1973). 
Using a combination of chemiluminescence detection 
on a Thermal Energy Analyzer and gas chromatographic 
technique, Atawodi and Spiegelhalder (1994) detected 
certain primary and secondary amines in some tropical 
plants of medicinal importance in Nigeria. Recently 
preformed volatile N-nitrosamines namely N-
nitrosodimethylamine (NDMA) was detected in the range 
of 1.2-3.4 µg/kg in four out of the 29 samples of certain 
Nigerian medicinal plant preparations indicating that 
microbial contamination of medicinal plant preparations 
may   contribute    to    N-nitroso    compound    formation 
(Atawodi, 2003). 
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N-nitrosamines represent a large group of compounds 
with a general mechanism of cancer induction. For 
instance, N-nitrosodimethylamine resulting from dietary 
exposure undergoes enzymatic hydroxylation and 
subsequent hydrolysis to an aldehyde and a 
monoalkylnitrosamine that rearranges and releases a 
carbocation that is reactive toward DNA bases (Loeppky, 
1999). CYP2E1 and CYP2A6 have been implicated in the 





Heterocyclic amines (HCAs) are formed from pyrolysates 
or heated materials from amino acids, proteins and meat 
(Sugimura, 1986). A number of HCAs have been purified 
and characterized and their carcinogenicity has been 
demonstrated in rodents. In rats and mice HCAs target 
the liver, lung, urinary bladder, small and large intestines, 
forestomach, skin, oral cavity, mammary glands, clitoral 
gland and prostate in the ventral lobe (Sugimura, 2002). 
HCAs have been shown to undergo metabolic 
activation to exocyclic amino groups and into 
hydroxyamino groups. CYP 1A2 isoform has been 
implicated in this conversion (Sugimura, 2002). Further 
activation may take place due to sulfonation or 
acetylation to form DNA adducts. The nitrenium ion has 
been proposed to be the likely ultimate carcinogen 
binding to the DNA bases (Colvin, 1998). Aside from CYP 
activation of HCAs, cyclooxygenase catalysed reaction 
has recently been proposed (Wiess et al., 2001). HCAs 
have been detected in the urine of volunteers taking 
ordinary dishes (Knize et al., 1997). Epidemiological 
studies have revealed the carcinogenicity of HCAs 
particularly colon cancer (Schiffman and Felton, 1990) 
but inconsistent results have been produced (Augustsson 
et al., 1999). 
MECHANISM OF CARCINOGENESIS 
 
Experiments in laboratory animals have characterized 
cancer formation as a series of complex steps. Generally 
cancer development has been considered to consist 
three major steps namely initiation, promotion and 
progression (Figure 1). Initiation, which is an irreversible 
process, starts when normal cells are exposed to 
carcinogenic substances and their DNA undergo damage 
that remain unrepaired or misread. In chemical 
carcinogenesis, initiation involves the uptake of a given 
carcinogen, which is subsequently distributed to organs 
for metabolism. Metabolic activation leads to reactive 
(electrophilic) species, which can bind to DNA rather than 
excretory carrier molecules. 
The binding can then cause coding errors at the time of 
replication leading to mutation. The somatic mutation in a 
damaged cell can then be reproduced during mitosis to 
produce clones of mutated cells. The next stage in the 
carcinogenesis process, which is promotion, is the 
expansion of the damaged cells to form an actively 
proliferating multi-cellular premalignant tumor cell 
population. The last stage known as progression is the 
irreversible process, which produces new clone of tumor 




MECHANISMS OF ANTICARCINOGENESIS 
 
Classifications of anticarcinogens 
 
Several classifications of the mechanisms of anticancer 
agents have been proposed by a number of investigators. 
Wattenberg (1985) subdivided anticarcinogens into two 
major categories; blocking agents and suppressing 
agents on the basis by which they exert protective effect 
at specific stages of multi-step carcinogenesis. Blocking
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Figure 2. Classification of chemopreventive agents based on their mechanisms of action 
 (Modified from Surh, 1999).  
 
 
agents are substances that can inhibit initiation either by 
inhibiting the formation of carcinogens from precursor 
molecules or reactive intermediates from the parent 
carcinogens, or by preventing the ultimate electrophilic 
species from interacting with macromolecules such as 
DNA, RNA and proteins (Figure 2). Suppressing gents 
act at the promotion or the progression stage by 
preventing the malignant expression of initiated cells. 
Some classifications of anticarcinogens distinguish 
inhibitors based on their intervention level throughout the 
process leading from a normal cell to an initiated cell, and 
then to dysplasia of increasing severity up to carcinoma 
in situ, and ultimately to cancer (Kelloff et al., 1994). 
De Flora (1998) presented a detailed classification of 
mechanisms of inhibitors of mutagenesis and 
carcinogenesis. A revised and updated classification was 
also proposed recently (De Flora et al., 2001). 
Accordingly, the classification took into consideration the 
multiple phases involved in the pathogenesis of cancer-
related diseases. It analyzed first the inhibition of 
mutation and of cancer initiation, either extracellularly or 
inside the cells and then the mechanisms interfering with 
promotion, progression, invasion and metastasis. A 
modified scheme incorporating possible points of 
intervention and some examples of dietary 
anticarcinogens proposed by De flora (1998) is presented 





In general terms three different levels of disease 
prevention has been identified namely primary prevention 
secondary prevention and tertiary prevention. Primary 
prevention means preventing the occurrence of diseases. 
Secondary prevention involves early diagnosis and 
intervention particularly at the preclinical stage with the 
objective of reversing, inhibiting or delaying the progress 
of the disease condition. Tertiary prevention deals with 
the reduction of the impact of the disease via prevention 
of complication and early deterioration (Last et al., 1986). 
The major part of the classification proposed by De 
flora (1998) falls within the scope of classification of 
chemopreventive agents based on their mechanisms of 
action. The term Chemoprevention, originally coined by 
Sporn and Roberts who used retinoids to inhibit 
experimental carcinogenesis (1984), is defined as the 
use of chemical substances (natural or synthetic) or their 
mixtures to suppress, delay or reverse the process of 
carcinogenesis (Surh, 1999). Chemoprevention therefore 
incorporates primary and secondary prevention while 
inhibition of invasion and metastasis is conversely 
outside chemoprevention and falls within tertiary 
prevention (De Flora, 1998). 
 
 
Biomolecular mechanisms of enzyme induction 
 
The probability that a carcinogen will reach a target cell 
and interact with DNA to cause damage is dependent on 
essentially two complementary mechanisms. Dietary 
carcinogens such as the aflatoxins, polycyclic aromatic 
hydrocarbons, heterocyclic amines and nitrosamines 
require metabolic activation to cause DNA damage and 
procarcinogens thereby modifying  or  creating  functional 
groups in the molecule. Anticarcinogens can elicit 







                 Table 1. Mechanisms by which dietary carcinogens protect against cancer. 
 
Mechanisms Examples 
Inhibition of cancer initiation by cellular 
mechanisms 
 
Blocking or competition  
Scavenging of reactive oxygen species Provitamins and vitamins (β-  carotene, Vit.C, VitE, 
polyphenols ,including epigallocatechin gallate and various 
anthocyanins. 
Protection of DNA nucleophiles Ellagic acid, retinoids, polyamines 




Modification of transmembrane protein Short chain fatty acids caproate, caprylate), 
acylglycosylsterols, dietary calcium 
Modulation of xenobiotic metabolizing enzymes  
Inhibition of procarcinogen activation Isothiocyanates monocyclic monoterpenes (limonene, 
methol, carveol),retinoids, flavonoids, wheat bran. 
Induction of detoxification pathways Polyphenols, indoles, diterpene esters, riboflavin 5’-
phosphate, S-allyl-L- cysteine, allylic sulphides 
Inhibition of tumor promotion  
Inhibition of genotoxic effect Chlorophyllin, retinoids, Oltipraz, natural and synthetic 
phenols 
Induction of cell proliferation Retinoids, calcium, deltanoids, 5’-azacytidine 
Antioxidant and scavenging of free radicals Provitamins and vitamins( β-  carotene, Vit.C, VitE), 
polyphenols 
Inhibition of tumor progression  
Signal transduction modulation PKC inhibitors ( tamoxifen, glycyrrhetinic acid, staurosporine.
Inhibition of proteases A variety of protease inhibitors 
Effects on the immune system Selenium, lipotropes, retinoids, vaccination with tumor-
specific antigens 
 




protection by inhibiting Phase 1 enzymes and/or 
byinduction of phase 2 enzymes, which leads to 
detoxification of the carcinogens. Monofunctional 
inducers induce phase 2 enzymes via the 
antioxidant/electrophile response element (ARE/EpRE) 
while bifunctional inducers induce both phase 2 and 
certain phase 1 enzymes through the Ah receptor and 









Resveratrol, trans-3,5,4'-trihydroxystilbene, is present in 
various plants, including grapes, berries and peanuts. A 
phytoalexin, it has been suggested to play pivotal role in 
cancer chemoprevention on the basis of its potent 
inhibitory effects on a number of cellular events linked 
with  cancer initiation, promotion and progression (Surh,  
1999). 
It has been speculated that at low doses (such as 
consumed in the common diet), resveratrol may have 
cardioprotective activity. In vitro and in vivo animal 
studies indicate that resveratrol modulates vascular cell 
function, inhibits LDL oxidation, suppresses platelet 
aggregation and reduces myocardial damage during 
ischemia-reperfusion (Bradamante et al., 2004). Other  
mechanism by which resveratrol protects the 
cardiovascular system include promotion of 
vasorelaxation, protection and maintenance of intact 
endothelium, anti-atherosclerotic properties, and 
estrogen-like actions (Hao and He, 2004). Besides 
cardioprotective effects, resveratrol exhibits anticancer 
properties, as suggested by its ability to suppress 
proliferation of a wide variety of tumor cells, including 
lymphoid and myeloid cancers, multiple myeloma; 
cancers of the breast, prostate, stomach, colon, 
pancreas, and thyroid; melanoma; head and neck 
squamous cell carcinoma; ovarian carcinoma; and  
cervical carcinoma (Aggarwal et  al.,  2004;  German  and  
Walzem, 2000). 
In mechanistic terms resveratrol has been reported to 





linkedenzymes involved in the oxidative metabolism of 
some polycyclic aromatic hydrocarbons (Teel and Huynh, 
1998). It is also a potent inducer of phase 2 enzymes 
such as DT-diaphorase (Uenobe et al., 1997). One other 
mechanism accounting for the chemopreventive role of 
resveratrol is its ability to suppress cycloxygenases 
(COX). Thus resveratrol was shown to inhibit COX-1 
activity in microsomes of sheep seminal vesicles (Jang et 
al., 1997) and inhibition of the inducible isozyme COX-2 
in cultured human mammary epithelial cells 
(Subbaramaiah et al., 1998). Resveratrol has been 
shown to suppress the activation of several transcription 
factors, including NF-kappaB, AP-1 and Egr-1 (Aggarwal 





Lycopene is a carotenoid abundantly present in tomatoes 
but in smaller amounts in other fruits such as grapefruit, 
guava, watermelon and papaya (Nguyen and Schwartz, 
1999). The significant antioxidant activity of lycopene has 
been reported. Hsiao et al. (2004) reported the 
scavenging activity of lycopene on DPPH radical in rat 
brain homogenates and its ability to inhibit nitric oxide 
formation in cultured microglia stimulated by 
lipopolysaccharide. The authors further demonstrated the 
protective effect of lycopene on ischemic brain injury in 
vivo. 
Epidemiological evidence strongly suggests that 
lycopene consumption and tomato products contribute to  
prostate cancer risk reduction. Experimental studies 
indicate that lycopene acts via different mechanisms, 
which have the potential to cooperate in reducing the 
proliferation of normal and cancerous prostate epithelial 
cells, in reducing DNA damage, and in improving 
oxidative stress defense. The mechanisms include 
inhibition of prostatic IGF-I signaling, IL-6 expression, and 
androgen signaling (Wertz et al., 2004). Moreover, 
lycopene improves gap-junctional communication and 
induces phase II drug metabolizing enzymes as well as 
oxidative defense genes. Lycopene was also 
demonstrated to inhibit mitogen-activated protein 
kinases, such as ERK1/2, p38 and JNK, and the 






Curcumin (diferuloylmethane) is the natural yellow 
pigment in turmeric isolated from the rhizome of the plant 
Curcuma longa.  It has gained wide acceptance in the 
Asian countries and it gives specific flavor and yellow 
colour to curry (Eigner and Scholz, 1999). Curcumin  was 
found to inhibit the generation of ROS including 
superoxide dismutase and hydrogen peroxide in 
peritoneal macrophages (Joe and Lokesh, 1994). It  




inhibits lipopolysaccharide and interferon-γ-induced 
production of nitric oxide in macrophages (Brouet and 
Oshima, 1994) and inhibition of inducible nitric oxide 
synthase gene expression in isolated BALB/c mouse 
peritoneal macrophages (Chan et al., 1998). Curcumin as 
an anti-inflammatory agent inhibits the proliferation of 
several tumour cells (Dorai et al., 2001). It exhibits anti 
clastogenic (Araujo and Leon, 2001), anti-fungal (Bartine 
and Tanaoui-Elaraki, 1997) and anti-viral properties 
(Barthelemy et al., 1998). 
Chemopreventive activity of curcumin has been 
indicated when administered before, during and after 
carcinogenic treatment as well as when administered 
during the promotion and progression phase of colon 
carcinogenesis in rats (Kawamori et al., 1999). Thus it 
has been shown that curcumin inhibited tumor initiation 
induced by benzo(a)pyrene and 7, 12-
dimethylbenz(a)anthracene and tumor promotion induced 
by phorbol esters (Deshpande and Maru, 1995;  Huang 
et al., 1995). Curcumin showed a dose-dependent 
decrease in cytochrome P450 and aryl hydrocarbon 
hydroxylase activity with a concomitant decrease in 
B(a)P-DNA adduct in cells treated with benzo(a) pyrene 
(Deshpande and Maru, 1995) . A similar study also 
revealed the inhibition of cytochrome P450 1A1 activity 
and formation of carcinogen-DNA adducts in 7, 12 
dimethylbenzanthracene-treated human mammary 
epithelial carcinoma (MCF-7) cells by competitively 






Kolaviron, a fraction of the deffated ethanol extract, 
containing Garcinia biflavonoid GB-1 GB-2 and 
kolaflavanone was isolated from the seed of Garcinia 
kola (Guttiferae) (1wu, 1985). The chemopreventive role 
of kolaviron in the presence of several heatocarcinogens  
(Farombi et al., 2000; Farombi, 2000; Farombi et al., 
2001; Farombi   2003a) and renal toxicant (Farombi et 
al., 2002a) has been well documented. Moreover 
kolaviron elicited significant hypoglycaemic effects when 
administered to normal and alloxan diabetic rabbits (Iwu 
et al., 1990). It also inhibited rat lens aldose reductase 
activity with an IC50 value of 5.4 X 10-6 suggesting the 
potential use of this compound as an antidiabetic agent.  
Kolaviron had been reported to interfere with hepatic drug 
metabolism (Braide, 1991; Farombi 2003b).  
Our data suggest that kolaviron does not affect phase 1 
drug metabolizing enzymes as judged by preservation of 
some representative phase 1 enzymes such as aniline 
hydroxylase (CYP 2E1), aminopyrine N-demethylase 
(CYP 2B1), ethoxyresorufin O-deethylase (CYP 1A1) and 
p-nitroanisole O-demethylase (CYP 2C11) (Farombi, 
2000). Our results however showed that kolaviron elicited 
a marked elevation in the activity of two phase 2 
representative enzymes- uridyldiphosphoglucuronosyl 
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Figure 3. Chemical structures of some chemopreventive agents. 
                                                         
 
transferase (UDPGT) and glutathione S-transferase 
transferase   (UDPGT)   and    glutathione   S-transferase  
(GST). 
The induction of phase 2 enzymes by kolaviron has 
been confirmed by the findings of Nwankwo et al. (2000) 
in Hep G 2 cells. The authors showed that GST isozyme 
α-1 and α-2.2 were induced by 2.2- and 2.5 fold levels  
respectively for their messages as determined by reverse  
transcription polymerase chain reaction (RT-PCR) and 
northern analysis and 2 fold increase in GSTα protein by 
western blotting when the cells were treated with 
CYP3A4 gene transcript by 3.7 fold at a concentration of 
90 µmol/l using northern blotting analysis (Nwankwo et 





bifunctional inducer according to the classification of 
(Greenwald et al. (1995).  
The antioxidant and antiradical properties of kolaviron 
has been reported. Our data showed that kolaviron (1.5 
mg/ml) elicited 85% inhibition of H2O2 scavenged 
superoxide generated by phenazine methosulfate NADH 
(PMS-NADH).  (Farombi et al., 2002b), scavenged 
hydroxyl radicals by inhibiting the oxidation of 
deoxyribose and inhibited lipid peroxidation in vivo 
(Farombi et al., 2000, Farombi, 2000). The antioxidant 
activity of kolaviron was further demonstrated by its ability 
to reduce background levels of protein oxidation 
biomarker (2-amino-adipic semialdehyde) in both plasma 
and liver of rats treated with kolaviron (200 mg/kg body 
weight) and decreased oxidative damage to DNA in the 
rat liver (Farombi et al., 2004a). Kolaviron was further 
demonstrated to significantly inhibit H2O2- and GSH/Fe3+-
induced strand breaks as well as ENDO III, and FPG 
sensitive sites, in human lymphocytes as well as rat liver 





Humans are unavoidably exposed to carcinogenic agents 
such as the heterocyclic amines, mycotoxins and other 
dietary carcinogens such as the nitrosamines. Although 
each one of these examples only occurs at low levels but 
the presence of these genotoxic substances may result in 
synergistic effects leading to cancer in humans. 
Chemopreventive strategies designed to limit both 
exposure to and the adverse health effects from dietary 
carcinogens are important public health goals to 
attenuate the incidence of diet-related neoplastic 
diseases since the complete elimination of exposure to 
these agents is not possible. It is reassuring that many 
food constituents consumed by the population contain 
potentially cancer preventive agents which are effective 
in preclinical models owing to their intrinsic antioxidant 
and anti-inflammatory properties. In view of the multifacet 
action of these naturally occurring chemopreventive 
agents, clinical application should be considered. 
However, one of the aspects that pose serious challenge 
to the future is to find, validate and introduce appropriate 
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